ELISA F29 -A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment.

• প্রধান লেখক: Rocio Rivero (লেখক), Mónica Inés Esteva (লেখক), Erya Huang (লেখক), Leylen Colmegna (লেখক), Jaime Altcheh (লেখক), Ulrike Grossmann (লেখক), Andrés Mariano Ruiz (লেখক), CHICO and CHICO SECURE Study Groups (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Public Library of Science (PLoS), 2023-06-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

<h4>Background</h4>Measurement of the success of antitrypanosomal treatment for Chagas disease is difficult, particularly in the chronic phase of the disease, because anti-Trypanosoma cruzi antibodies persist in serum for prolonged periods. We studied the effects of nifurtimox administer...